Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Acq. announced
Appointed director
|
|
Ocuphire Pharma, Inc. (OCUP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/17/2022 |
SC 13G
| Richmond Brothers, Inc. reports a 6.2% stake in Ocuphire Pharma, Inc. |
| 03/26/2021 |
SC 13G
| Apexian Pharmaceuticals, Inc. reports a 7.1% stake in Ocuphire Pharma, Inc. |
| 03/16/2021 |
SC 13G
| Sooch Mina reports a 11.8% stake in Ocuphire Pharma, Inc. |
| 11/16/2020 |
SC 13G
| Richmond Brothers, Inc. reports a 5.8% stake in Ocuphire Pharma, Inc. |
| 11/16/2020 |
SC 13G
| Altium Capital Management LP reports a 8.3% stake in Ocuphire Pharma, Inc. |
| 11/12/2020 |
SC 13G
| Empery Asset Management, LP reports a 8.3% stake in Ocuphire Pharma, Inc. |
| 08/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/04/2019 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Rexahn Pharmaceuticals, Inc. |
| 10/29/2018 |
SC 13G
| Anson Funds Management LP reports a 5.1% stake in Rexahn Pharmaceuticals, Inc. |
| 10/26/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/29/2016 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.3% stake in Rexahn Pharmaceuticals, Inc. |
| 11/10/2015 |
SC 13G
| Empery Asset Management, LP reports a 8.4% stake in Rexahn Pharmaceuticals, Inc. |
| 12/04/2012 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 9.6% stake in Rexahn Pharmaceuticals, Inc. |
| 01/28/2011 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|
|